| |
|
|
|
|
|
|
| |
About
Logos Technologies |
|
| Logos
Technologies is a leading provider of
world-class integrated clinical trial
solutions to the world’s pharmaceutical,
biotechnology and clinical research
organisations.
Logos Technologies help their clients
accelerate
research and development and thereby
reduce the development time of life saving and
life enhancing drugs. The ALPHADAS Suite is a
clinical study management and fully mobile
Phase I electronic data capture system. The main
benefits of the system provide a reliable,
portable solution for EDC, integrate clinical
and laboratory operations, accelerate data
throughput and enhance data integrity.
ALPHADAS also improves compliance with the
regulatory authorities by providing a
systematic process to facilitate Data
Management and QA review.
Logos
Technologies established and proven product
ALPHADAS is beginning to set the standard in
collecting Phase I clinical trial data |
|
|
|
|
|
|
|
|
|
|
|
Kendle
International to Implement Logos Technologies
ALPHADAS Clinical Trial Solutions |
|
London,
UK, 22nd November 2004,
Logos
Technologies, the leading provider of solutions
for Phase I clinical trials, today announced
that Kendle International Inc. (NASDAQ: KNDL), a leading, global full-service clinical
research organization, has purchased an
enterprise licence for Logos Technologies
ALPHADAS® Clinical Data Management
and Phase I Site Tool Kit (STK™) solutions.
|
|
|
|
|
|
|
These
established and proven solutions will help Kendle in
streamlining its existing clinical data processes and
are expected to provide significant cost savings. The
efficiencies created by ALPHADAS and Phase I STK will
provide Kendle with an additional competitive
advantage and will enable the company to deliver more
effective Phase I solutions for its customers.
“We look
forward to building on our existing relationship with
Kendle and to establishing a long lasting client
partnership,” said Mr. Giles Wilson, Business
Development Director of Logos Technologies. “We are
confident that the implementation will meet Kendle’s
expectation and provide many profitable and cost-
saving benefits,” he continued.
|
|
Logos’
Clinical Data Management solution will provide Kendle
with a powerful and effective tool for collecting, monitoring
and cleaning clinical
trial data. Utilising
Logos Technologies Phase I Site Tool Kit will increase
efficiency by automating processes, and rapidly reduce
study setup times.
“The
ALPHADAS product from Logos Technologies will allow us
to fully automate our Phase I activities globally,
thereby creating efficiencies in the tracking and
processing of clinical study data,” said Missie
Williams-Kaull, Vice President, Clinical Operations,
of Kendle International’s Phase I unit in
Morgantown, W. Va.”
For further information please contact the Logos Technologies Press Office by emailing
here |
|
|
About Kendle International Inc.
Kendle International Inc. (Nasdaq: KNDL) is among
the world’s leading global clinical research
organizations. We deliver innovative and robust
clinical development solutions — from first-in-man
studies through market launch and surveillance — to
help the world’s biopharmaceutical companies
maximize product life cycles and grow market share.
With headquarters in Cincinnati and more than 1,700
associates worldwide, Kendle has conducted clinical
trials or provided regulatory and validation services
in more than 60 countries. Investor kits are available
upon request from Kendle International Inc., 1200
Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or
from the company’s Web site at www.kendle.com. |
|
|
|
|
 |
